【拍一发五】 康字头云南本草仍痛宁喷剂发炎止疼上 牙龈肿痛 d2 未发货秒退 "康字头云南本草伢痛宁草本护理喷剂"仍然在售，相关宣传视频已下架。 "治多种牙痛问题：吃饭牙痛、喝水牙痛、虫牙蛀牙、吃凉牙痛、牙龈肿痛、牙周炎痛""我们比牙医更加快捷更加方便，适合随身便携、病发即止"。这是新 京报今年11月刊发的《"能治多种牙痛、效果太猛"，康字头草本口鼻护理液涉嫌虚假宣传》报道中，在某电商平台的康字头工厂直发店，一款名为"康字头 云南本草伢痛宁草本护理喷剂"产品介绍视频中的内容。医生提醒，这种宣称能治疗多种疾病的"大而全"的产品，往往是"一眼假"。 近日，记者就上述报道所涉问题进行回访，在电商平台的产品销售页面，前述视频已经下架。不过，店铺客服的回复与此前相同，仍表示产品可"逐步修复 保护牙齿，修护口腔微环境，抑制细菌滋生"。就记者此前在12315平台的留言咨询，武汉市硚口区市场监督管理局12月19日向记者反馈，现场检查发现前述 店铺备案企业——武汉麦臻选网络科技有限公司未在注册地实际经营，已将其列入异常经营名录。 产品介绍视频下架，客服仍宣称"治病"功效 目前，这款"康字头云南本草伢痛宁草本护理喷剂"的售价没有 ...

南极磷虾油问题产品事件，最新进展来了！ 12月16日，"上海市消保委"官微发布消息称，上海市消保委就南极磷虾油相关问题产品约谈企业。 上海市消保委12月11日发表的文章显示，一款标称"北京同仁堂99%高纯南极磷虾油"的产品，在网页上写着"高含量""智利进口原料""高度提纯""1粒≈100 只磷虾"，其磷脂标识值为43%，看似是品质出众的优质产品，但检测结果显示该款产品磷脂含量为0。 12月15日下午，上海市消保委针对北京同仁堂南极磷虾油产品的相关问题，约谈了该产品的经销商与生产商。 生产商安徽哈博药业有限公司陈述，涉事产品由经销商北京同仁堂（四川）健康药业有限公司定制采购，采购价格远低于正常水平，产品包装按照北京同 仁堂（四川）健康药业有限公司要求制作，所有涉事产品均供给北京同仁堂（四川）健康药业有限公司，由其对外销售。 安徽哈博药业有限公司承认，在生产过程中未添加其对外宣称的"南极磷虾油"。经销商北京同仁堂（四川）健康药业有限公司在约谈中回避问题推脱责 任，声称对产品的涉嫌造假行为毫不知情，与己无关。 上海市消保委经过大量调查，认为涉事企业存在涉嫌故意造假行为，既侵犯消费者合法权益，也违反市场经营诚信原则。 ...

【导读】上海市消保委就南极磷虾油相关问题产品约谈企业，产品与宣传严重不符 中国基金报记者 晨曦 南极磷虾油问题产品事件，最新进展来了！ 12 月 16 日， " 上海市消保委 " 官微发布消息称，上海市消保委就南极磷虾油相关问题产 品约谈企业。 上海市消保委经过大量调查，认为涉事企业存在涉嫌故意造假行为，既侵犯消费者合法权 益，也违反市场经营诚信原则。其一，涉事企业明知产品中未添加 " 南极磷虾油 " ，却宣称 磷脂含量 43% ，与宣传严重不符；其二，涉事产品在包装与营销宣传上存在刻意混淆误导行 为。 对此，上海市消保委敦促北京同仁堂（四川）健康药业有限公司：立即自查，如实向广大消 费者说明情况；就侵害消费者合法权益的行为，向消费者做出诚恳道歉；与生产商一起尽快 召回问题产品，为消费者办理退换货并依法赔偿。同时，上海市消保委已及时函告四川有关 监管部门关注此事。 上海市消保委 12 月 11 日发表的文章显示，一款标称 " 北京同仁堂 99% 高纯南极磷虾油 " 的产品，在网页上写着 " 高含量 "" 智利进口原料 "" 高度提纯 ""1 粒 ≈100 只磷虾 " ，其 磷脂标识值为 43% ，看似是品质出 ...

Core Viewpoint - The article highlights the swift action taken by the Xiamen Market Supervision Administration in response to reports of false advertising related to "imported" blood sugar control drinks, leading to the removal of certain products from the market and ongoing investigations into the involved companies [1][4][5]. Regulatory Response - The Xiamen Market Supervision Administration has initiated an investigation into the companies involved in the false advertising of blood sugar control products, specifically targeting the "Kongtangwei" and "Breorqy" brands [1][5]. - The regulatory body has mandated the removal of product links and is conducting further investigations to address the reported violations [1][5][6]. Market Impact - The article notes that the false claims made by these products, such as being "imported" and having extraordinary effects on blood sugar control, misled consumers and posed challenges to diabetes treatment [4][5]. - The cost of the "Kongtangwei" product is estimated to be less than 10 yuan, while it is sold for over 100 yuan, indicating significant markup based on misleading claims [4]. Ongoing Issues - Despite the removal of certain products, many others continue to be sold with unchanged promotional content, indicating a persistent issue with false advertising in the market [7][8]. - The article points out that various other products, including chromium supplements and herbal teas, also make unverified claims regarding their effectiveness in controlling blood sugar levels [5][8]. Recommendations for Improvement - Experts suggest that regulatory efforts need to be strengthened, particularly in enhancing the oversight of e-commerce platforms to prevent the sale of products with exaggerated claims [8][9]. - There is a call for improved collaboration among regulatory bodies across different regions to ensure comprehensive monitoring and enforcement against misleading advertising practices [8][9].

Core Viewpoint - The article highlights the issue of false advertising in fish oil products sold through live streaming, prompting regulatory actions from the State Administration for Market Regulation (SAMR) in China [1] Regulatory Actions - SAMR has initiated enforcement checks in provinces including Anhui, Shanghai, Zhejiang, and Guangdong in response to the reported false claims regarding fish oil products [1] - Three specific non-compliant fish oil products were identified: "Huacheng·Astaxanthin Deep Sea Fish Oil Gummy Candy," "Huacheng·Deep Sea Polyunsaturated Fish Oil Gummy Candy," and "Deep Sea Polyunsaturated Fish Oil (Sugar-Free) Gummy Candy" [1] - The Anhui market regulatory department conducted immediate inspections on the involved companies, leading to investigations against Anhui Gusu Yuan Pharmaceutical Co., Ltd. and Anhui Runfeng Health Technology Co., Ltd. [1] Legal Violations - The companies are being investigated for potential violations of the Food Safety Law of the People's Republic of China and the Anti-Unfair Competition Law [1] - Local market regulatory authorities have engaged with platform representatives to address the illegal product listings, and false advertising cases have been referred to relevant market regulatory departments for legal action [1]